Author | Luke Nordquist, MD | OncLive

Author | Luke Nordquist, MD

Articles

Dr. Luke Nordquist on Who Should Receive Radium-223

October 21, 2016

Video

Luke Nordquist, MD, a urologic medical oncologist and CEO of the Urology Cancer Center and GU Research Network, discusses which patients may benefit from radium-223, those who should not receive the drug, and combinations that are being considered.

Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC

September 17, 2016

Video

Luke Nordquist, MD, a urologic medical oncologist and CEO of the Urology Cancer Center and GU Research Network, discusses a prospective study looking at the impact of an additional 6 doses of radium-223 dichloride in patients with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases.

x